A
Ankur Varma
Associate Professor
faculty
COM | Internal Med Hem-Onc
14 h-index
88 pubs
932 cited
Research Areas
Biography and Research Information
OverviewAI-generated summary
Ankur Varma researches hematopoietic stem cell transplantation, with a focus on treatment outcomes and associated complications. His work has investigated factors influencing outcomes in patients undergoing allogeneic stem cell transplants, including the role of donor-specific anti-HLA antibodies and the impact of myeloablative total body irradiation on graft-versus-host disease. Varma has also explored specific complications such as hyperhemolysis in sickle cell disease and Human herpesvirus 6-associated hyponatremia. His research includes clinical trials, such as a Phase 1 study of briquilimab in combination with conditioning regimens for acute myeloid leukemia and myelodysplastic syndrome. Varma's publications also address myeloproliferative neoplasms in blast phase and emerging syndromes like immune effector cell-associated HLH-like syndrome. He has an h-index of 14 and has authored 86 publications.
Metrics
- h-index: 14
- Publications: 88
- Citations: 932
Selected Publications
-
Nonmyeloablative Conditioning Combined with Anti-CD117 Antibody Briquilimab in Older Adults with High-Risk AML and MDS (2026)
-
Real-World Survival Outcomes of CAR-T and Bispecific T-cell Engagers in Patients with relapsed/refractory DLBCL (2026)
-
Impact of the CAR-T era on survival in diffuse large B-cell lymphoma: A u.S. population-based cohort study (2025)
-
Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis (2025)
-
Revaccination status after bone marrow transplant and chimeric antigen receptor T-cell therapy. (2025)
-
Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature (2025)
-
The Effect of Sickle Cell Disease on Seizure-Related Hospitalizations: An Analysis of the Nationwide Inpatient Sample 2021 (2025)
-
Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study. (2025)
-
Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances (2025)
-
Simultaneous Presentation of Relapsed Diffuse Large B-cell Lymphoma and Extrapulmonary Tuberculosis in a Patient With HIV: A Case Report (2025)
-
Strategies to Optimize Overutilization of Provider-Ordered Peripheral Blood Smear Review in an University Hospital Setting (2024)
-
Impact of Response to Bridging Therapy on Outcomes of CAR-T Therapy in Relapsed/Refractory DLBCL: A Single Center Retrospective Analysis (2024)
-
Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy (2024)
-
Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021) (2024)
-
Eculizumab for Hyperhemolysis in Sickle Cell Disease: Key Insights From a Challenging Case (2024)
Grants & Funding
- MYELOMATCH, Master Screening and Reassessment Protocol (MSRP) for Tier Advancement in the NCI myeloMATCH Clinical Trials NIH/Nat. Cancer Institute - Pass Through: SouthWest Oncology Group Principal Investigator
- MYELOMATCH, Master Screening and Reassessment Protocol (MSRP) for Tier Advancement in the NCI myeloMATCH Clinical Trials NIH/Nat. Cancer Institute - Pass Through: SouthWest Oncology Group Principal Investigator
Collaboration Network
Top Collaborators
Mamatha Gaddam
University of Arkansas for Medical Sciences
10 shared publications
In database
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
- Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy
Showing 5 of 10 shared publications
Cesar Gentille Sanchez
University of Arkansas for Medical Sciences (US)
10 shared publications
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- Eculizumab for Hyperhemolysis in Sickle Cell Disease: Key Insights From a Challenging Case
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
Showing 5 of 10 shared publications
Nishanth Thalambedu
University of Arkansas for Medical Sciences
8 shared publications
In database
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- HL-697 Demographics and Survival Outcomes of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Retrospective Analysis of SEER Database
- Demographics and Survival Outcomes of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Retrospective Analysis of SEER Database
- Eculizumab for Hyperhemolysis in Sickle Cell Disease: Key Insights From a Challenging Case
Showing 5 of 8 shared publications
Sruthi Vellanki
Willis-Knighton Cancer Center (US)
8 shared publications
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- HL-697 Demographics and Survival Outcomes of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Retrospective Analysis of SEER Database
- Demographics and Survival Outcomes of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Retrospective Analysis of SEER Database
- Eculizumab for Hyperhemolysis in Sickle Cell Disease: Key Insights From a Challenging Case
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
Showing 5 of 8 shared publications
Muthu Sendhil Kumaran
University of Arkansas for Medical Sciences (US)
8 shared publications
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
- Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy
- Strategies to Optimize Overutilization of Provider-Ordered Peripheral Blood Smear Review in an University Hospital Setting
Showing 5 of 8 shared publications
Samer A. Srour
The University of Texas MD Anderson Cancer Center (US)
6 shared publications
- ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies
- Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era
- Supplementary Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Supplementary Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
Showing 5 of 6 shared publications
Alan Baltz
University of Arkansas for Medical Sciences
6 shared publications
In database
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021)
- Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy
- Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study.
- Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis
Showing 5 of 6 shared publications
Sunita Nathan
Rush University Medical Center (US)
5 shared publications
- Myeloablative TBI is associated with increased risk of pulmonary GVHD in patients undergoing allogeneic hematopoietic stem cell transplant
- Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient
- Letermovir Prophylaxis Outcomes in Allogeneic Hematopoietic Cell Transplant Recipients
- Human Herpesvirus-6 Infection and Calcineurin Inhibitor Pain Syndrome Interaction after Umbilical Cord Blood Transplant
- The Impact of Non-Clinical Factors in Clinical Trial Enrollments of Patients with Hematologic Malignancies
Celalettin Üstün
Rush University Medical Center (US)
5 shared publications
- Myeloablative TBI is associated with increased risk of pulmonary GVHD in patients undergoing allogeneic hematopoietic stem cell transplant
- Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient
- Letermovir Prophylaxis Outcomes in Allogeneic Hematopoietic Cell Transplant Recipients
- Human Herpesvirus-6 Infection and Calcineurin Inhibitor Pain Syndrome Interaction after Umbilical Cord Blood Transplant
- The Impact of Non-Clinical Factors in Clinical Trial Enrollments of Patients with Hematologic Malignancies
Qaiser Bashir
5 shared publications
- Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era
- Supplementary Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Supplementary Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
Amin M. Alousi
5 shared publications
- Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era
- Supplementary Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Supplementary Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
Rohtesh S. Mehta
5 shared publications
- Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era
- Supplementary Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Supplementary Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
Uday Popat
5 shared publications
- Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era
- Supplementary Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Supplementary Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
Akash Mukherjee
Winthrop Rockefeller Foundation
5 shared publications
In database
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
- Supplementary Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Supplementary Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
- Data from Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
Lori Muffly
Stanford University (US)
4 shared publications
- Final Results from Phase 1 Study of Briquilimab, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning, Shows Durable Remissions in Older Adults with Acute Myeloid Leukemia in Complete Remission and Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
- Preliminary Data from a Phase 1 Study of JSP191, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning Is Well-Tolerated, Facilitates Chimerism and Clearance of Minimal Residual Disease in Older Adults with MDS/AML Undergoing Allogeneic HCT
- Immune Biomarkers Associated with Chronic Gvhd in Phase 1 Study of JSP191, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning in Older Adults with MDS/AML Undergoing Allogeneic HCT
- Subanalysis from Phase 1 Study of JSP191, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning, Shows Durable Remissions in Older Adults with Acute Myleoid Leukemia in Complete Remission Undergoing Allogeneic Hematopoietic Cell Transplantation
Similar Researchers
Based on overlapping research topics
Lauren Appell
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Immune Response and Inflammation
Cancer Treatment and Pharmacology
A Almashayekh
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Immune Response and Inflammation
Cancer Treatment and Pharmacology
Thomas E. Goodwin
Hendrix College
Immune Response and Inflammation
Cancer Treatment and Pharmacology
Metabolism and Genetic Disorders
Mouad Abdulrahim
Hendrix College
Immune Response and Inflammation
Cancer Treatment and Pharmacology
Metabolism and Genetic Disorders
Jeanette M. Ramos
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Immune Response and Inflammation
Microbial infections and disease research
Lori Dean
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Metabolism and Genetic Disorders
Microbial infections and disease research